Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
The Institute for Myeloma and Bone Cancer Research is an independent, non-profit cancer research institute dedicated to finding a cure for multiple myeloma, a plasma cell cancer found in bone marrow. More than 100,000 people are diagnosed with myeloma every year and it is estimated that more than 1,000,000 are living with myeloma worldwide. IMBCR was founded in 2004 by leading myeloma researcher and oncologist, Dr. James R. Berenson whose research in both the clinic and the laboratory has spanned more than 25 years. Research conducted at IMBCR has created many of the novel-therapeutics used for myeloma patients worldwide.